Drug name - Vistogard

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6258795 WELLSTAT THERAP Acylated uridine and cytidine and uses thereof Jul, 2023

(9 months from now)

US7776838 WELLSTAT THERAP Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides Aug, 2027

(4 years from now)

Drugs and Companies using URIDINE TRIACETATE ingredient

Treatment: Emergency treatment of adult & pediatric patients following fluorouracil or capecitabine overdose,or who exhibit early-onset,severe or life-threatening cardiac or cns toxicity or unusually severe adverse reactions within 96 hours


More Information on Dosage
Strength Dosage Availability

availability in other generic markets.

Click on the highlighted region to filter.